BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11388837)

  • 21. Structure based design of benzophenone-based non-thiol farnesyltransferase inhibitors.
    Schlitzer M
    Curr Pharm Des; 2002; 8(19):1713-22. PubMed ID: 12171543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of potent imidazole and cyanophenyl containing farnesyltransferase inhibitors with improved oral bioavailability.
    Tong Y; Lin NH; Wang L; Hasvold L; Wang W; Leonard N; Li T; Li Q; Cohen J; Gu WZ; Zhang H; Stoll V; Bauch J; Marsh K; Rosenberg SH; Sham HL
    Bioorg Med Chem Lett; 2003 May; 13(9):1571-4. PubMed ID: 12699757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3-Imidazolylmethylaminophenylsulfonyltetrahydroquinolines, a novel series of farnesyltransferase inhibitors.
    Ding CZ; Hunt JT; Ricca C; Manne V
    Bioorg Med Chem Lett; 2000 Feb; 10(3):273-5. PubMed ID: 10698452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3-Aryl-4-aryloyl-1-(1H-imidazol-5-yl)methylpyrrole, a novel class of farnesyltransferase inhibitors.
    Lee H; Lee J; Shin Y; Jung W; Kim JH; Park K; Ro S; Chung HH; Koh JS
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2963-5. PubMed ID: 11677136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-thiol farnesyltransferase inhibitors: utilization of the near aryl binding site by 5-arylacetylaminobenzophenones.
    Mitsch A; Böhm M; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2004 Apr; 337(4):213-8. PubMed ID: 15065081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation of farnesyltransferase inhibitors from herbal medicines.
    Kwon BM; Lee SH; Kim MJ; Kim HK; Kim HM
    Ann N Y Acad Sci; 1999; 886():261-4. PubMed ID: 10667234
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthesis of conformationally constrained 5,6,7, 8-Tetrahydroimidazo[1,5-a]pyridine inhibitors of farnesyltransferase.
    Dinsmore CJ; Zartman CB; Baginsky WF; O'Neill TJ; Koblan KS; Chen IW; McLoughlin DA; Olah TV; Huff JR
    Org Lett; 2000 Nov; 2(22):3473-6. PubMed ID: 11082012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of farnesyltransferase with A-176120, a novel and potent farnesyl pyrophosphate analogue.
    Tahir SK; Gu WZ; Zhang HC; Leal J; Lee JY; Kovar P; Saeed B; Cherian SP; Devine E; Cohen J; Warner R; Wang YC; Stout D; Arendsen DL; Rosenberg S; Ng SC
    Eur J Cancer; 2000 Jun; 36(9):1161-70. PubMed ID: 10854950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of tripeptidyl farnesyltransferase inhibitors.
    Lee HY; Sohn JH; Kwon BM
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1599-602. PubMed ID: 12039571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-Aminopyrrolidinone farnesyltransferase inhibitors: design of macrocyclic compounds with improved pharmacokinetics and excellent cell potency.
    Bell IM; Gallicchio SN; Abrams M; Beese LS; Beshore DC; Bhimnathwala H; Bogusky MJ; Buser CA; Culberson JC; Davide J; Ellis-Hutchings M; Fernandes C; Gibbs JB; Graham SL; Hamilton KA; Hartman GD; Heimbrook DC; Homnick CF; Huber HE; Huff JR; Kassahun K; Koblan KS; Kohl NE; Lobell RB; Lynch JJ; Robinson R; Rodrigues AD; Taylor JS; Walsh ES; Williams TM; Zartman CB
    J Med Chem; 2002 Jun; 45(12):2388-409. PubMed ID: 12036349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, and characterization of piperazinedione-based dual protein inhibitors for both farnesyltransferase and geranylgeranyltransferase-I.
    Qiao Y; Gao J; Qiu Y; Wu L; Guo F; Lo KK; Li D
    Eur J Med Chem; 2011 Jun; 46(6):2264-73. PubMed ID: 21440964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Andrastins A-C, new protein farnesyltransferase inhibitors produced by Penicillium sp. FO-3929. I. Producing strain, fermentation, isolation, and biological activities.
    Omura S; Inokoshi J; Uchida R; Shiomi K; Masuma R; Kawakubo T; Tanaka H; Iwai Y; Kosemura S; Yamamura S
    J Antibiot (Tokyo); 1996 May; 49(5):414-7. PubMed ID: 8682716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wharton-fragmentation-based approach to the carbocyclic core of the phomoidrides.
    Murphy GK; Hama N; Bedermann A; Dong P; Schneider CM; McMahon TC; Tao RN; Twenter BM; Spiegel DA; Wood JL
    Org Lett; 2012 Sep; 14(17):4544-7. PubMed ID: 22917221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformational restriction of flexible ligands guided by the transferred noe experiment: potent macrocyclic inhibitors of farnesyltransferase.
    Dinsmore CJ; Bogusky MJ; Culberson JC; Bergman JM; Homnick CF; Zartman CB; Mosser SD; Schaber MD; Robinson RG; Koblan KS; Huber HE; Graham SL; Hartman GD; Huff JR; Williams TM
    J Am Chem Soc; 2001 Mar; 123(9):2107-8. PubMed ID: 11456854
    [No Abstract]   [Full Text] [Related]  

  • 35. Farnesyltransferase inhibitors inhibit the growth of malaria parasites in vitro and in vivo.
    Wiesner J; Kettler K; Sakowski J; Ortmann R; Katzin AM; Kimura EA; Silber K; Klebe G; Jomaa H; Schlitzer M
    Angew Chem Int Ed Engl; 2004 Jan; 43(2):251-4. PubMed ID: 14695623
    [No Abstract]   [Full Text] [Related]  

  • 36. Pepticinnamins, new farnesyl-protein transferase inhibitors produced by an actinomycete. I. Producing strain, fermentation, isolation and biological activity.
    Omura S; Van der Pyl D; Inokoshi J; Takahashi Y; Takeshima H
    J Antibiot (Tokyo); 1993 Feb; 46(2):222-8. PubMed ID: 8468235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RPR 130401, a nonpeptidomimetic farnesyltransferase inhibitor with in vivo activity.
    Vrignaud P; Bissery MC; Mailliet P; Lavelle F
    Ann N Y Acad Sci; 1999; 886():249-51. PubMed ID: 10667231
    [No Abstract]   [Full Text] [Related]  

  • 38. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
    Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural products with maleic anhydride structure: nonadrides, tautomycin, chaetomellic anhydride, and other compounds.
    Chen X; Zheng Y; Shen Y
    Chem Rev; 2007 May; 107(5):1777-830. PubMed ID: 17439289
    [No Abstract]   [Full Text] [Related]  

  • 40. 3,8-Diazabicyclo[3.2.1]octan-2-one peptide mimetics: synthesis of a conformationally restricted inhibitor of farnesyltransferase.
    Dinsmore CJ; Bergman JM; Bogusky MJ; Culberson JC; Hamilton KA; Graham SL
    Org Lett; 2001 Mar; 3(6):865-8. PubMed ID: 11263902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.